SUMMARY Serum C-reactive protein (CRP) and creatine kinase (CK) MB levels were measured prospectively in patients with definite myocardial infarction, patients with spontaneous or exerciseinduced angina, subjects undergoing coronary arteriography, and patients with non-cardiac chest pain. All individuals with infarction developed raised CRP levels and there was a significant correlation between the peak CRP and CK MB values. The CRP, however, peaked around 50 hours after the onset of pain at a time when the CK MB, which peaked after about 15 hours, had already returned to normal. In 20 patients who recovered uneventfully, CRP levels fell, returning to normal about seven days after infarction in four cases who were followed to this point. In eight complicated cases, including four who died within the first 10 days, the CRP level remained high. Angina alone or coronary arteriography did not cause a rise in the CRP or CK MB concentrations. Increased CRP production is a non-specific response to tissue injury and raised CRP levels in cases of chest pain with a normal CK MB indicated a pathological process other than myocardial infarction. Regular monitoring of CRP levels may also assist in early recognition of intercurrent complications occurring after myocardial infarction.
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Differential diagnosis of myocardial infarction from other causes of chest pain is a common clinical problem. Even when the diagnosis is established there are many difficult questions such as: recognition of myocardial necrosis in patients with known ischaemic heart disease, recognition of intercurrent complications in the post-infarct period, prognosis in the immediate post-infarct period, and assessment of convalescent infarct patients for discharge from the coronary care unit to the ward, and from ward to home.
C-reactive protein (CRP) is the classical acute phase reactant,' the serum level of which has long been known to increase after myocardial infarction.2-5 Earlier work, using relatively insensitive and semiquantitative assays, suggested that serial measurement of serum CRP levels may be useful in the diagnosis and management of myocardial infarction.2 3 We have reinvestigated this possibility in a prospective study of well-characterised patients using a precise quantitative assay for CRP, together with measurements of CK MB, the specific myocardial isoenzyme of creatine kinase. 6
Accepted for publication 24 All patients with definite myocardial infarction mounted a CRP response and there was a statistically significant correlation between the peak levels of CRP and of CK MB (Fig. 1 , Kendall's rank correlation coefficient r=0-441, p<0.001). Two individuals had relatively modest peak CRP levels. One was a 74-year-old woman in whom temporal arteritis had been diagnosed one year previously and who was on daily prednisolone therapy. The other was a 40-year-old Negro from the West Indies who had no known antecedent disease or treatment. The peak level of CRP occurred later after the onset of pain than did the peak level of CK MB, the mean±SD time to peak being 50-5+23-3 hours for CRP and 14-8+8*6 hours for CK MB. In 20 uncomplicated cases who made a good recovery the CRP concentration fell from its peak within 12 to 24 hours and in four patients who were followed for a sufficient period, it remained at low levels thereafter. In eight cases, however, in whom progress during the immediate post-infarct period was interrupted by cardiac insufficiency resulting from arrhythmias or a low output state the CRP concentration did not return to normal. Four patients who died within the first 10 days all had persistently high or rising CRP levels at the time of death. These Fig. 4 Serial CRP and CK MB values in a 60-year-old man with known ischaemic heart disease after acute admission to the coronary care unit with severe chest pain. There was no evidence ofinfarction but he suffered a septicaemic illness associated with the presence of intravascular lines. ---, upper limit ofnormal for CK MB.
-------group.bmj.com on December 22, 2017 -Published by http://heart.bmj.com/ Downloaded from hours he improved and became afebrile, the CRP falling promptly towards normal, and he made an uneventful recovery. Staph. epidermidis was subsequently grown from the blood and the catheter tip obtained before starting antibiotics.
Another example of the potential value of regular, frequent, and rapid monitoring of CRP is provided by the case of a 37-year-old Indian man who was admitted to hospital with a clinical diagnosis of crescendo angina. The chest radiograph was normal but the electrocardiogram showed slight left ventricular hypertrophy. Over the next 42 hours there was no rise in CK MB, aspartate aminotransferase, or any other routinely measured biochemical variable. A slight fever developed but the pain abated and the patient insisted on discharging himself. He experienced further pain at home during the next few days but refused to be readmitted and he died five days later. Necropsy was refused so the causes of his pain and demise are unknown. Subsequent assay of his serum CRP, however, showed that it rose from a normal value of 2 mg/l on admission to 42 mg/l at 17 hours, 70 mg/l at 28 hours, and 76 mg/l at 42 hours. These high levels indicate unequivocally the onset and progression of a tissue-damaging organic disease process and if available at the time might have assisted in the patient's management or at least facilitated his continued stay in hospital.
Discussion
Increased CRP production is a non-specific response to most forms of cell death, tissue injury, infection, or inflammation, and it is clear that myocardial necrosis is a potent stimulus. All the patients studied here in whom there was a significant rise in CK MB also showed a rise in CRP concentration, and though this was relatively modest in two cases (one of whom was on steroids), there was a significant correlation between the peak values attained by these two completely distinct variables. Similar results have recently been reported in abstract form by Catheline et A rise in CRP in cases of chest pain without raised CK MB strongly suggests a non-infarctive or noncardiac lesion and may assist in diagnosis of the cause of pain or in early recognition of intercurrent complications in cases of angina or after infarction. For example, if the CRP results in the case illustrated in Fig. 4 had been available at the time rather than after the event, cultures could have been taken before the onset of fever or other symptoms, his intravascular catheters changed, and prophylactic antibiotics begun much earlier. Assay of CRP may also provide an objective criterion to assist in decisions regarding suitability of individual patients for transfer from the coronary care unit to the ward or from the ward to home. On all these grounds we suggest that, provided the results are interpreted in the light of detailed knowledge of the patients' clinical condition and in conjunction with CK MB values, regular assay of CRP may play a valuable part in differential diagnosis of the chest pain syndrome and in management of individuals with known or suspected myocardial ischaemia or infarction. 
